Toward personalized treatment for gastroesophageal adenocarcinoma (GEC): Strategies to address tumor heterogeneity—Pangea.

Authors

Daniel Catenacci

Daniel Virgil Thomas Catenacci

University of Chicago, Chicago, IL

Daniel Virgil Thomas Catenacci , Blase N. Polite , Les Henderson , Peng Xu , Brittany Rambo , Wei-Li Liao , Todd A. Hembrough , Lei Zhao , Shu-Yuan Xiao , John Hart , Theodore Karrison , James J. Dignam , Hedy Lee Kindler

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Translational Research

Citation

J Clin Oncol 32, 2014 (suppl 3; abstr 66)

DOI

10.1200/jco.2014.32.3_suppl.66

Abstract #

66

Poster Bd #

B43

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Gastrointestinal Cancers Symposium

FGFR2-amplified gastroesophageal adenocarcinoma is a distinct genomic class: Lessons learned from a liquid biopsy platform.

FGFR2-amplified gastroesophageal adenocarcinoma is a distinct genomic class: Lessons learned from a liquid biopsy platform.

First Author: Bushra Shariff

Poster

2021 Gastrointestinal Cancers Symposium

Genomic characterization of a comprehensive collection of esophagogastric cancer patient-derived xenografts.

Genomic characterization of a comprehensive collection of esophagogastric cancer patient-derived xenografts.

First Author: Ryan H. Moy

Poster

2019 Gastrointestinal Cancers Symposium

<em>FGFR2-</em>altered gastroesophageal adenocarcinomas (GEA) are a rare clinicopathologic entity with a distinct genomic landscape.

FGFR2-altered gastroesophageal adenocarcinomas (GEA) are a rare clinicopathologic entity with a distinct genomic landscape.

First Author: Samuel Jacob Klempner

First Author: Takuma Yokoyama